The presently available therapies for type 2 diabetes have not been able to achieve normoglycemic status in a majority of the patients which may be either due to the limitations of the drug itself or its side effects. In an effort to develop potent and safe oral antidiabetic agents, 4-ethyloxychalcone, which was found to be the most potent antiglycating agent in our previous study, has been evaluated for its in vivo hypoglycemic activity using an alloxanized diabetic rat model. The diabetes was induced in rats by injection of intraperitoneal alloxan. However, the oral route was used for the administration of 4-ethyloxychalcone. A significant glucose-lowering effect (P < 0.05) comparable with the standard glibenclamide has been observed for 4-ethyloxychalcone in an oral glucose tolerance test. 4-Ethyloxychalcone also produced a significant decrease (P < 0.05) in fasting blood glucose levels during the 42 days of treatment. Furthermore, a significant lowering (P < 0.05) of glycated hemoglobin (HbA1C ) level was also shown by 4-ethyloxychalcone after 42 days of treatment. Thus, 4-ethyloxychalcone might be regarded as a potential hypoglycemic agent that can act as a platform for the development of future antidiabetic drugs.
Research on Chemical Intermediates – Springer Journals
Published: Sep 21, 2015
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera